Telaprevir activity in treatment-naive patients infected with hepatitis C virus genotype 4.
作者信息
Sefcik Roberta K, Bichoupan Kian, Martel-Laferrière Valérie, Odin Joseph A, Liu Lawrence U, Perumalswami Ponni, Bansal Meena, Dieterich Douglas T, Ahmad Jawad, Schiano Thomas D, Branch Andrea D
机构信息
Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York.
出版信息
J Infect Dis. 2014 Dec 1;210(11):1855-6. doi: 10.1093/infdis/jiu360. Epub 2014 Jun 26.
Abstract
摘要
相似文献
1
Telaprevir activity in treatment-naive patients infected with hepatitis C virus genotype 4.替拉瑞韦在初治丙型肝炎病毒4型感染患者中的活性。
J Infect Dis. 2014 Dec 1;210(11):1855-6. doi: 10.1093/infdis/jiu360. Epub 2014 Jun 26.
2
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.替拉瑞韦在初治感染 HCV 基因 4 型患者中的疗效：一项随机试验。
J Infect Dis. 2013 Sep;208(6):1000-7. doi: 10.1093/infdis/jit274. Epub 2013 Jun 24.
3
Telaprevir: changing the standard of care of chronic hepatitis C.特拉匹韦：改变慢性丙型肝炎的治疗标准。
J Postgrad Med. 2013 Jan-Mar;59(1):42-7. doi: 10.4103/0022-3859.109493.
4
[Studies with telaprevir].[替拉瑞韦的研究]
MMW Fortschr Med. 2011 Jul 21;153(29-31):15.
5
Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy.丙型肝炎基因1b型和4型在基于特拉匹韦的治疗后得到治愈。
Rev Esp Enferm Dig. 2015 Apr;107(4):251.
6
Study Results Support Telaprevir-Based Therapy for HCV.研究结果支持基于特拉匹韦的丙型肝炎病毒治疗方案。
AIDS Patient Care STDS. 2010 Nov;24(11):746.
7
8
Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes.分析用特拉匹韦治疗的基因型 2 和 3 型丙型肝炎病毒变异体显示出在各基因型中一致的耐药谱。
J Viral Hepat. 2013 Jun;20(6):395-403. doi: 10.1111/jvh.12046. Epub 2013 Jan 10.
9
Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.替拉瑞韦：用于治疗基因 1 型慢性丙型肝炎的综述。
Drugs. 2012 Mar 26;72(5):619-41. doi: 10.2165/11208370-000000000-00000.
10
Optimal treatment with telaprevir for chronic HCV infection.替拉瑞韦治疗慢性丙型肝炎感染的最佳方案。
Liver Int. 2013 Feb;33 Suppl 1:3-13. doi: 10.1111/liv.12079.
本文引用的文献
1
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial.替拉瑞韦在初治感染 HCV 基因 4 型患者中的疗效：一项随机试验。
J Infect Dis. 2013 Sep;208(6):1000-7. doi: 10.1093/infdis/jit274. Epub 2013 Jun 24.
Zotero 插件